In addition to the short proposal, PhD students must develop and present to their supervisory committee an NIH-style dissertation proposal. This proposal must be submitted to committee members prior to the formulation of the general examination. The Committee typically meets with the student at least once following the submission of NIH-style proposal to address any issues and further discuss the project. After the discussion, the student is excused and the committee discusses possible questions to include on the General Examination.
- Sections 1 and 2 should comprise no more than 13 page.
- Use 11-point Arial font; minimum 0.5 inch margins
The following table outlines the required sections:
State concisely the goals of the proposed research and summarize the expected outcome(s), including the impact that the results of the proposed research will exert on the research field(s) involved. List succinctly the specific objectives of the research proposed, e.g., to test a stated hypothesis, create a novel design, solve a specific problem, challenge an existing paradigm or clinical practice, address a critical barrier to progress in the field, or develop new technology.
Length: One page or less
Include the following subsections:
Significance: Explain the importance of the problem or critical barrier to progress in the field that the proposed project addresses. Explain how the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields. Describe how the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved.
Innovation: Explain how the application challenges and seeks to shift current research or clinical practice paradigms. Describe any novel theoretical concepts, approaches or methodologies, instrumentation or intervention(s) to be developed or used, and any advantage over existing methodologies, instrumentation or intervention(s). Explain any refinements, improvements, or new applications of theoretical concepts, approaches or methodologies, instrumentation or interventions.
Approach: Describe the overall strategy, methodology, and analyses to be used to accomplish the specific aims of the project. Include how the data will be collected, analyzed, and interpreted as well as any resource sharing plans as appropriate. Discuss potential problems, alternative strategies, and benchmarks for success anticipated to achieve the aims. If the project is in the early stages of development, describe any strategy to establish feasibility, and address the management of any high risk aspects of the proposed work. Point out any procedures, situations, or materials that may be hazardous to personnel and precautions to be exercised.
Preliminary Studies. Include information on Preliminary Studies as part of the Approach section. Discuss the PI's preliminary studies, data, and/or experience pertinent to this application.
Length: Up to 12 pages, depending on the complexity of the hypotheses and methods used to address them
|Student's Role and Data Collection Requirement||
Describe your role in the project (e.g., idea, design, data collection, data management, analysis). Describe how the requirement of original data collection will be met by this project. (see previous section in this document for details of acceptable data collection.)
Length: One page or less
|Protection of Human Subjects||
Risks To The Subjects
Adequacy Of Protection Against Risks
Potential Benefits Of The Proposed Research To The Subjects and Others
Importance Of The Knowledge To Be Gained
NOTE: Test articles (investigational new drugs, devices, or biologicals) including test articles that will be used for purposes or administered by routes that have not been approved for general use by the Food and Drug Administration (FDA) must be named. State whether the 30-day interval between submission of applicant certification to the FDA and its response has elapsed or has been waived and/or whether use of the test article has been withheld or restricted by the Food and Drug Administration, and/or the status of requests for an IND or IDE covering the proposed use of the test article in the Research Plan.
Data And Safety Monitoring Plan
Length: As many pages as are necessary to address the topics
Provide a bibliography of any references cited in the previous sections. Each reference must include the names of all authors (in the same sequence in which they appear in the publication), the article and journal title, book title, volume number, page numbers, and year of publication. Include only bibliographic citations. The references should be limited to literature that is current and/or relevant to the proposed research.